Survival in Patients with Degenerative Mitral Stenosis: Results from a Large Retrospective Cohort Study

Ioana Pasca1, Patricia Dang2, Gaurav Tyagi2

  • 1Division of Anesthesiology, Loma Linda University Medical Center, Loma Linda, California.

Insights

Survival for patients with severe mitral annular calcification causing degenerative mitral stenosis (DMS) is poor. Age, renal insufficiency, atrial fibrillation, and other valve issues worsen prognosis, while certain medications may improve survival.

Area of Science:

  • Cardiology
  • Valvular Heart Disease
  • Echocardiography

Background:

  • Severe mitral annular calcification (MAC) causing degenerative mitral stenosis (DMS) is a growing concern in valve intervention patients.
  • The clinical profile, natural history, and survival factors in DMS patients are not well-understood.

Purpose of the Study:

  • To characterize factors influencing survival in patients diagnosed with degenerative mitral stenosis (DMS).

Main Methods:

  • A cohort of 1,004 patients with DMS was identified from an institutional echocardiographic database.
  • Survival analysis was performed using clinical, pharmacologic, and echocardiographic variables.

Main Results:

  • 1- and 5-year survival rates were 78% and 47%, respectively, with worse outcomes in higher DMS grades.
  • Risk factors for mortality included older age, atrial fibrillation, renal insufficiency, mitral/tricuspid regurgitation, elevated right atrial pressure, aortic stenosis, and low albumin.
  • Renin-angiotensin system blockers and statins were associated with better survival; digoxin use correlated with higher mortality.

Conclusions:

  • Prognosis for DMS patients is poor, particularly in the elderly and those with comorbidities like renal insufficiency and atrial fibrillation.
  • Concomitant valvular lesions also negatively impact survival.
  • Renin-angiotensin system blockers and statins may offer survival benefits, while digoxin use warrants caution.
Abstract

Related Concept Videos

Mitral Stenosis III: Medical Management01:26

Mitral Stenosis III: Medical Management

Mitral stenosis, a condition marked by the narrowing of the mitral valve, necessitates an integrated approach for effective management. This approach includes preventative measures, medical therapy, and surgical interventions to reduce symptoms and prevent complications.PreventionPrevention of mitral stenosis primarily focuses on reducing the incidence of bacterial infections, particularly streptococcal infections, which can lead to rheumatic fever and subsequent valvular damage. Timely...
427
Mitral Stenosis IV: Nursing Management01:27

Mitral Stenosis IV: Nursing Management

A comprehensive nursing assessment is essential for patients with valvular heart disease, which involves any dysfunction of the heart valves that could impact blood flow and overall heart function.Subjective Data Collection:Chief Complaint and Present Illness: Start with the patient's primary concerns, focusing on the onset, duration, and progression of cardiac symptoms such as dyspnea, fatigue, chest pain, and palpitations.Past Medical History: Collect detailed information on any previous...
360
Mitral Stenosis II: Clinical features and Diagnostic Tests01:23

Mitral Stenosis II: Clinical features and Diagnostic Tests

Mitral stenosis is a heart condition in which the mitral valve, which allows blood to flow from the left atrium to the left ventricle, becomes narrowed or stenotic. This narrowing hinders blood flow and leads to clinical symptoms requiring specific medical evaluations and management strategies. The following overview outlines the clinical symptoms, assessments, diagnostic findings, prevention methods, and treatments for mitral stenosis.Clinical ManifestationsDyspnea (shortness of breath): This...
404
Mitral Stenosis I: Introduction01:22

Mitral Stenosis I: Introduction

Mitral Valve Stenosis (MVS) is a heart condition where the mitral valve narrows, impeding blood circulation from the left atrium to the left ventricle. The etiology and pathophysiology of this condition are multifaceted, leading to a cascade of cardiovascular complications.Causes of Mitral Valve StenosisRheumatic Heart Disease: It is the main cause of mitral valve stenosis, particularly in developing nations. This condition arises from rheumatic fever, an inflammatory illness resulting from...
1.2K
Mitral Regurgitation III: Medical Management01:25

Mitral Regurgitation III: Medical Management

Mitral regurgitation (MR) is characterized by retrograde blood circulation from the left ventricle into the left atrium due to inadequate mitral valve closure. The severity of the condition, symptoms, and underlying cause determine treatment strategies.Monitoring and Pharmacological TreatmentPatients with mild to moderate MR typically do not need immediate intervention but regular monitoring to assess progression and guide treatment. Patients with mild MR should have an echocardiogram every 3-5...
521
Mitral Regurgitation IV: Nursing Management01:28

Mitral Regurgitation IV: Nursing Management

Mitral regurgitation (MR) is a condition where the mitral valve does not close properly, leading to the backward flow of blood from the left ventricle into the left atrium during systole. This condition can arise from various causes, including rheumatic fever, infective endocarditis, or degenerative valve disease. Effective nursing management is crucial to optimizing patient outcomes and involves comprehensive assessment and targeted interventions.Comprehensive Patient AssessmentA detailed...
499